DK0984936T3 - Cyanoguanidiner som celleproliferationsinhibitorer - Google Patents

Cyanoguanidiner som celleproliferationsinhibitorer

Info

Publication number
DK0984936T3
DK0984936T3 DK98924052T DK98924052T DK0984936T3 DK 0984936 T3 DK0984936 T3 DK 0984936T3 DK 98924052 T DK98924052 T DK 98924052T DK 98924052 T DK98924052 T DK 98924052T DK 0984936 T3 DK0984936 T3 DK 0984936T3
Authority
DK
Denmark
Prior art keywords
stands
cyanoguanidines
alkoxycarbonyl
carboxy
alkoxy
Prior art date
Application number
DK98924052T
Other languages
Danish (da)
English (en)
Inventor
Charlotte Schou
Erik Rytter Ottosen
Original Assignee
Leo Pharma As With Secondary N
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As With Secondary N filed Critical Leo Pharma As With Secondary N
Application granted granted Critical
Publication of DK0984936T3 publication Critical patent/DK0984936T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK98924052T 1997-05-29 1998-05-15 Cyanoguanidiner som celleproliferationsinhibitorer DK0984936T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9711123.1A GB9711123D0 (en) 1997-05-29 1997-05-29 Novel cyanoguanidines
PCT/DK1998/000193 WO1998054141A1 (en) 1997-05-29 1998-05-15 Cyanoguanidines as cell proliferation inhibitors

Publications (1)

Publication Number Publication Date
DK0984936T3 true DK0984936T3 (da) 2004-01-05

Family

ID=10813253

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98924052T DK0984936T3 (da) 1997-05-29 1998-05-15 Cyanoguanidiner som celleproliferationsinhibitorer

Country Status (21)

Country Link
US (2) US6346520B1 (de)
EP (1) EP0984936B1 (de)
JP (1) JP4349476B2 (de)
KR (1) KR100549631B1 (de)
CN (1) CN1121389C (de)
AT (1) ATE248819T1 (de)
AU (1) AU733000B2 (de)
CA (1) CA2292775C (de)
CZ (1) CZ293275B6 (de)
DE (1) DE69817810T2 (de)
DK (1) DK0984936T3 (de)
ES (1) ES2206931T3 (de)
GB (1) GB9711123D0 (de)
HK (1) HK1027568A1 (de)
HU (1) HUP0003823A3 (de)
NZ (1) NZ501266A (de)
PL (1) PL190249B1 (de)
PT (1) PT984936E (de)
RO (1) RO119880B1 (de)
RU (1) RU2194697C2 (de)
WO (1) WO1998054141A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000061561A1 (en) 1999-04-09 2000-10-19 Shionogi Bioresearch Corp. Cyanoguanidine compounds
AU1494702A (en) 2000-11-21 2002-06-03 Leo Pharma As Cyanoguanidine prodrugs
ATE442362T1 (de) 2001-05-24 2009-09-15 Leo Pharma As Pyridylcyanoguanidin verbindungen
US20030045515A1 (en) * 2001-05-24 2003-03-06 Lise Binderup Combination medicament for treatment of neoplastic diseases
US7253193B2 (en) 2002-05-17 2007-08-07 Leo Pharma A/S Cyanoguanidine prodrugs
WO2006066584A1 (en) 2004-12-22 2006-06-29 Leo Pharma A/S Novel cyanoguanidine compounds
CA2701071C (en) 2007-09-26 2018-03-27 Gemin X Pharmaceuticals Canada Inc. Compositions and methods for effecting nad+ levels using a nicotinamide phosphoribosyl transferase inhibitor
US8173677B2 (en) 2007-09-26 2012-05-08 Gemin X Pharmaceuticals Canada Inc. Compositions and methods for effecting NAD+ levels using a nicotinamide phosphoribosyl transferase inhibitor
CA2751495C (en) * 2009-02-06 2013-08-20 Tianjin Hemay Bio-Tech Co., Ltd. Pharmaceutical compositions comprising a pyridyl cyanoguanidine and cyclodextrin and/or derivatives thereof
US8912184B1 (en) 2010-03-01 2014-12-16 Alzheimer's Institute Of America, Inc. Therapeutic and diagnostic methods
EP2634173A4 (de) 2010-10-26 2014-04-02 Tianjin Hemay Bio Tech Co Ltd Polymorph von n-(6-(4-chlorphenoxy-)hexyl-)n'-cyano-n''-(4-pyridyl-)guanidin, herstellung davon und verwendung dafür

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9219472D0 (en) * 1992-09-15 1992-10-28 Leo Pharm Prod Ltd Chemical compounds
GB9711125D0 (en) * 1997-05-29 1997-07-23 Leo Pharm Prod Ltd Novel cyanoguanidines
AU1494702A (en) * 2000-11-21 2002-06-03 Leo Pharma As Cyanoguanidine prodrugs

Also Published As

Publication number Publication date
CA2292775C (en) 2009-10-13
HUP0003823A3 (en) 2001-09-28
HK1027568A1 (en) 2001-01-19
DE69817810T2 (de) 2004-07-01
KR20010013164A (ko) 2001-02-26
KR100549631B1 (ko) 2006-02-08
PL190249B1 (pl) 2005-11-30
EP0984936A1 (de) 2000-03-15
PL337059A1 (en) 2000-07-31
RO119880B1 (ro) 2005-05-30
JP2001526692A (ja) 2001-12-18
ES2206931T3 (es) 2004-05-16
EP0984936B1 (de) 2003-09-03
US20020107400A1 (en) 2002-08-08
CZ293275B6 (cs) 2004-03-17
US6646129B2 (en) 2003-11-11
WO1998054141A1 (en) 1998-12-03
CN1258277A (zh) 2000-06-28
CA2292775A1 (en) 1998-12-03
CZ9904240A3 (cs) 2001-01-17
CN1121389C (zh) 2003-09-17
US6346520B1 (en) 2002-02-12
PT984936E (pt) 2004-02-27
AU733000B2 (en) 2001-05-03
NZ501266A (en) 2001-09-28
HUP0003823A2 (en) 2001-03-28
DE69817810D1 (de) 2003-10-09
JP4349476B2 (ja) 2009-10-21
GB9711123D0 (en) 1997-07-23
RU2194697C2 (ru) 2002-12-20
AU7638398A (en) 1998-12-30
ATE248819T1 (de) 2003-09-15

Similar Documents

Publication Publication Date Title
SE0202463D0 (sv) Novel compounds
DK0984938T3 (da) Cyanoguanidiner som celleproliferationsinhibitorer
NO20066055L (no) Pyridinderivater
MA28279A1 (fr) Derives d'indole et utilisation de ceux-ci comme inhibiteurs de kinase, notamment des inhibiteurs de ikk2
HK1080470B (zh) 雜環化合物
DE60226469D1 (de) Biphenylkarbonsäureamidderivate als p38 kinase-inhibitoren
ATE253545T1 (de) Biarylessigsäure-derivate und ihre verwendung als cox-2 inhibitoren
EP1248612A4 (de) Neue substanzen und verbindungen als protease-inhibitoren
DE69928697D1 (de) Sulfohydroxamsäure and sulfohydroxamate und ihre verwendung als mek-inhibitoren
HK1053463A1 (en) Aminobenzophenones as inhibitors of il-1B and TNF-a.
IL166271A0 (en) Pyrrolidinedione substituted piperidine phthalazone derivatives and pharmaceutical compositions containing the same
DE60334536D1 (de) Furylverbindungen
NZ547615A (en) Quinoline derivatives and use thereof as mycobacterial inhibitors
DE60333746D1 (de) Thienylverbindungen
DE60230127D1 (de) Inhibitoren von integrin alpha-v-beta-6
DK0984936T3 (da) Cyanoguanidiner som celleproliferationsinhibitorer
BRPI0407841A (pt) inibidores heterocìclicos de quinase
BG103867A (en) Cyanoguanidines as cell proliferation inhibitors
TW200628153A (en) Novel compounds
HUP0003942A2 (hu) Helyettesített 3,3-diamino-2-propén-nitrilek, előállításuk és alkalmazásuk
SE0302756D0 (sv) Novel Compounds
NO20072078L (no) Indolderivater som inhibitorer av loselig adenylsyklase
NO20055749L (no) Sulfamat benzotiofenderivater som steroid sulfatase inhibitorer
EA200600100A1 (ru) Производные никотинамида, полезные в качестве ингибиторов pde4
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren